Eukaryotic DNA topoisomerase IIβ

BioEssays

Volumn 20, Issue 3, 1998, Pages 215-226

  Austin, Caroline A ^a   Marsh, Katherine L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II BETA; ETOPOSIDE;

AMINO ACID SEQUENCE; ANIMAL; CELL CYCLE; CHEMISTRY; DNA SUPERCOILING; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; NEOPLASM; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; DNA TOPOISOMERASES, TYPE II; DNA, SUPERHELICAL; DNA-BINDING PROTEINS; ETOPOSIDE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0032032797     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q     Document Type: Review

References (79)

1. Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635-692.
2. Watt PM, and Hickson ID (1994) Structure and function of type II DNA topoisomerases Biochem J 303:681-695.
3. Drake FH, Zimmerman JP, McCabe FL, Bartus HF, Per SR, Sullivan DM, Ross WE, Mattern MR, Johnson RK, Crooke ST, and Mirabelli CK (1987) Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells: Evidence for two forms of the enzyme. J Biol Chem 262:16739-16747.
4. Drake FH, Hofman GA, Bartus HF, Mattern MR, Crooke ST, and Mirabelli CK (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 28:154-8160.
5. Tsai Pflugfelder M, Liu LF, Liu AA, Tewey KM, Whang Peng J, Knutsen T, Huebner K, Croce CM, and Wang JC (1988) Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci USA 85:7177-7181.
6. Chung TDY, Drake FH, Tan KB, Per SR, Crooke ST, and Mirabelli CK (1989) Characterization and immunological identifcation of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci USA 86:9431-9435.
7. Austin CA, and Fisher LM (1990) Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells. FEBS Lett 266:115-117.
8. Austin CA, Sng JH, Patel S, and Fisher LM (1993) Novel HeLa topoisomerase II is the IIβ isoform Complete coding sequence and homology with other type II topoisomerases. Biochim Biophys Acta 1172:283-291.
9. Jenkins JR, Ayton P, Jones T, Davies SL, Simmons DL, Harris AL, Sheer D, and Hickson ID (1992) Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res 20: 5587-5592.
10. Davies SL, Jenkins JR, and Hickson ID (1993) Human cells express two differentially spliced forms of topoisomerase IIβ mRNA. Nucleic Acid Res 21:3719-3723.
11. Chen AY, and Liu LF (1994) DNA topoisomerases:essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218.
12. Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlhagan G, and Kohn KW (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530-542.
13. Roca J, Ishida R, Berger JM, Andoh T, and Wang JC (1994) Antitumor bisdiooxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci USA 91:1781-1785.
14. Sehested M, and Jensen PB (1996) Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle. Biochem Pharmacol 51:879-886.
15. Tsutsui K, Tsutsui K, Okada S, Watanabe M, Shohmori T, Seki S, and Inoue Y (1993) Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development. J Biol Chem 268:19076-19083.
16. Caron PR, and Wang JC (1994) Alignment of primary sequences of DNA topoisomerases. Adv Pharmacol 29B:271-297.
17. Tan KB, Dorman TE, Falls KM, Chung TD, Mirabelli CK, Crooke ST, and Mao J (1992) Topoisomerase IIα and topoisomerase IIβ genes: Characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res 52:231-234.
18. Sng JH, Austin CA, and Fisher LM (1992) Cloning the human topoisomerase 11α gene. Abstract P03 at the 4th conference on DNA topoisomerases in therapy.
19. Wasserman RA, Austin CA, Fisher CA, and Wang JC (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: Expression of a functional recombinant human DNA topoisomerase IIα in yeast. Cancer Res 53:3591-3596.
20. Austin CA, Marsh KL, Wasserman RA, Willmore E, Sayer PJ, Wang JC, and Fisher LM (1995) Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase IIβ. J Biol Chem 270:15739-15746.
21. Meczes EL, Marsh KL, Fisher LM, Rogers MP, and Austin CA (1997) Complementation of temperature sensitive topoisomerase II mutations in S. cerevisiae by a human TOP2β construct allows the study of topoisomerase IIβ inhibitors in yeast. Cancer Chemother Pharmacol 39:367-375.
22. Marsh KL, Willmore E, Tinelli S, Cornarotti M, Meczes EL, Capranico G, Fisher LM, and Austin CA (1996) Amsacrine-promoted DNA cleavage site determinants for the two human DNA topoisomerase II isoforms a and β. Biochem Pharmacol 52:1675-1685.
23. Cornarotti M, Tinelli S, Willmore E, Zunino F, Fisher LM, Austin CA, and Capranico G (1996) Drug sensitivity and sequence specificity of human recombinant DNA topoisomerase IIα (p170) and β (p180) Mol Pharmacol 50:1463-1471.
24. Spitzner JR, In Kwon C, Gootz TD, McGuirk PR, and Muller MT (1995) Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug dependent and independent recognition elements. Mol Pharmacol 48:238-249.
25. Danks MK, Qiu J, Catapano CV, Schmidt CA, Beck WT, and Fernandes DJ (1994) Subcellular distribution of the a and β topoisomerase II-DNA complexes stabilized by VM-26. Biochem Pharmacol 48:1785-1795.
26. Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, and Holguin MH (1995) Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res 55:1707-1716.
27. Dereuddre S, Frey S, Delaporte C, and Jacquemin Sablon A (1995) Cloning and characterisation of full length cDNAs coding for the DNA topoisomerase IIβ from Chinese hamster lung cells sensitive and resistant to 9-OH-ellipticine. Biochim Biophys Acta 1264:178-182.
28. Sullivan DM, Glisson BS, Hodges PK, Smallwood-Kentro S, and Ross WE (1986) Proliferation dependence of topoisomerase II mediated drug action. Biochemistry 25:2248-2256.
29. Berger JM, Gamblin SJ, Harrison SC, and Wang JC (1996) Structure and mechanism of DNA topoisomerase II. Nature 379:225-232.
30. Biersack H, Jensen S, Gromova I, Nielsen IS, Westergaard O, and Andersen AH (1996) Active heterodimers are formed from human DNA topoisomerase IIα and IIβ isoforms. Proc Natl Acad Sci USA 93:8288-8293.
31. Capranico G, Tinelli S, Austin CA, Fisher ML, and Zunino F (1992) Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta 1132:43-48.
32. Watanabe M, Tsutsui K, Tsutsui K, and Inoue Y (1994) Differential expressions of the topoisomerase IIα and β mRNAs in developinq rat brain. Neurosci Res 19:51-57.
33. Juenke JM, and Holden JA (1993) The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. Biochim Biophys Acta 1216:191-196.
34. Holden JA, Rolfson DH, and Wittwer CT (1992) The distribution of immunoreactive topoisomerase II protein in human tissues and neoplasms. Oncology Res 4:157-166.
35. Zandvliet DWJ, Hanby AM, Austin CA, Marsh KL, Clark IBN, Wright NA, and Poulsom R (1996) Analysis of foetal expression sites of human type II DNA topoisomerases α and β mRNAs by in situ hybridisation. Biochim Biophys Acta 1307:239-247.
36. Bauman ME, Holden JA, Brown KA, Harker WG, and Perkins SL (1997) Differential immunohistochemical staining for DNA topoisomerase IIα and β in human tissues and for DNA topoisomerase IIβ in non-Hodgkin's lymphomas. Mod Pathol 10:168-175.
37. Turley H, Comley M, Houlbrook S, Nozaki N, Kikuchi A, Hickson ID, Gatter K, and Harris AL (1997) The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Br J Cancer 75:1340-1346.
38. Woessner RD, Chung TDY, Hofmann GA, Mattern MR, Mirabelli CK, Drake FH, and Johnson RK (1990) Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170 kD and 180 kD forms of topoisomerase II. Cancer Res 50:2901-2908.
39. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, and Drake FH (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Diff 2:209-214.
40. Meyer KN, Kjeldsen E, Straub T, Knudsen BR, Hickson ID, Kikuchi A, Kreipe H, and Boege F (1997) Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic activities. J Cell Biol 136:775-788.
41. Goswami PC, Roti Roti JL, and Hunt CR (1996) The cell cycle coupled expression of topoisomerase IIα during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol Cell Biol 16:1500-1508.
42. Kroll DJ, and Rowe TC (1991) Phosphorylation of DNA topoisomerase II in a human tumor cell line. J Biol Chem 266:7957-7961.
43. Heck MMS, Hittleman WN, and Earnshaw WC (1988) Differential expression of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086-1090.
44. Nakajima T, Morita K, Ohi N, Arai T, Nozaki N, Kikuchi A, Osaka F, Yamao F, and Oda K (1996) Degradation of topoisomerase IIα during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J Biol Chem 271:24842-24849.
45. Cardenas ME, and Gasser SM (1993) Regulation of topoisomerase II by phosphorylation: A role for casein kinase II. J Cell Sci 104:219-225.
46. Burden DA, Goldsmith LJ, and Sullivan DM (1993) Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II. Biochem J 293:297-304.
47. Burden DA, and Sullivan DM (1994) Phosphorylation of the alpha- and beta-isoforms of DNA topoisomerase II is qualitatively different in interphase and mitosis in Chinese hamster ovary cells. Biochemistry 33: 14651-14655.
48. Wells NJ, and Hickson ID (1995) Human topoisomerase IIα is phosphorylated in a cell cycle phase dependent manner by a proline directed kinase. Eur J Biochem 231:491-497.
49. Wells NJ, Fry AM, Guano F, Norbury C, and Hickson ID (1995) Cell-cycle phase specific phosphorylation of human topoisomerase II alpha: Evidence of a role for protein kinase C. J Biol Chem 270:28357-28363.
50. Wells NJ, Addison CM, Fry AM, Ganapathi R, and Hickson ID (1994) Serine-1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitro. J Biol Chem 269:29746-29751.
51. Ishida R, Iwai M, Marsh KL, Austin CA, Yano T, Shibata M, Nozaki N, and Kara A (1996) Threonine-1342 in human topoisomerase IIα is phosphorylated throughout the cell cycle. J Biol Chem 271:30077-30082.
52. Taagepera S, Rao PN, Drake FH, and Gorbsky GJ (1993) DNA topoisomerase IIα is the major chromosome protein recognised by the mitotic phosphoprotein antibody MPM2. Proc Natl Acad Sci USA 90:8407-8411.
53. Fukunaga R, and Hunter T (1997) MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921-1933.
54. Kimura K, Saijo M, Ui M, and Enomoto T (1994) Growth state and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase. J Biol Chem 269:1173-1176.
55. Kimura K, Nozaki N, Saijo M, Kikuchi A, Ui M, and Enomoto T (1994) Identification of the nature of modification that causes the shift of DNA topoisomerase IIβ to apparent higher molecular weight forms in the M phase. J Biol Chem 269:24523-24526.
56. Kimura K, Nozaki N, Enomoto T, Tanaka M, and Kikuchi A (1996) Analysis of M phase specific phosphorylation of DNA topoisomerase II. J Biol Chem 271:21439-21445.
57. Kimura K, Saijo M, Tanaka M, and Enomoto T (1996) Phosphorylation-independent stimulation of DNA topoisomerase IIα activity. J Biol Chem 271:10990-10995.
58. Taya Y (1997) RB kinases and RB binding proteins: New points of view. Trends Biochem Sci 22:14-17.
59. Feldhoff PW, Mirski SEL, Cole SPC, and Sullivan DM (1994) Altered subcellular distribution of topoisomerase IIalpha in a drug-resistant human small cell lung cancer cell line. Cancer Res 54:756-762.
60. Swedlow JR, Sedat JW, and Agard DA (1993) Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field microscopy. Cell 73:97-108.
61. Darby MK, Schmitt B, Jongstra Bilen J, and Vosberg HP (1985) Inhibition of calf thymus type II DNA topoisomerase by poly (ADP-ribosylation) EMBO J 4:2129-2134.
62. Mahjan R, Delphin C, Guan T, Gerace L, and Melchior F (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to the nuclear pore complex protein RanBP2. Cell 88:97-107.
63. Rattner JB, Hendzel MJ, Furbee CS, Muller MT, and BazettJones DP (1996) Topoisomerase IIα is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J Cell Biol 134:1097-1107.
64. Warburton PE, and Earnshaw WC (1997) Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function. Bioessays 19:97-99.
65. Chaly N, and Brown DL (1996) Is DNA topoisomerase IIβ a nucleolar protein? J Cell Biochem 63:162-173.
66. Sumner AT (1996) The distribution of topoisomerase II on mammalian chromosomes. Chromosome Res 4:5-14.
67. Petrov P, Drake FH, Loranger A, Huang W, and Hancock R (1993) Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 204:73-81.
68. Chaly N, Chen X, Dentry J, and Brown DL (1996) Organisation of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells. Chromosome Res 4:457-466.
69. Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NR, and Astaldi Ricotti GCB (1992) Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170 and 180 kDa isozymes. Exp Cell Res 200:452-459.
70. Zini N, Martelli AM, Sabatelli P, Santi S, Negri C, Ricotti GCBA, and Maraldi NM (1992) The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp Cell Res 200:460-466.
71. Jensen S, Redwood CS, Jenkins JR, Andersen AH, and Hickson ID (1996) Human DNA topoisomerase IIα and IIβ can functionally substitute for yeast TOP2 in chromosome segregation and recombination. Mol Gen Genet 252:79-86.
72. Varga-Weisz PD, Wilm M, Bonte E, Dumas K, Mann M, and Becker PB (1997) Chromatin remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 388,598-602.
73. Watt PM, Louis EJ, Borts RH, and Hickson ID (1995) Sgs1: A eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell 81 :253-260.
74. Wang X, Watt PM, Louis EJ, Borts, RH, and Hickson ID (1996) Pat1: A topoisomerase II-associated protein required for faithful chromosome transmission in Saccharomyces cerevisiae. Nucleic Acids Res 24:4791-4797.
75. Bhat MA, Philp AV, Glover DM, and Bellen HJ (1996) Chromatid segregation at anaphase requires the barren product, a novel chromosome associated protein that interacts with topoisomerase II. Cell 87:1103-1114.
76. Saitoh N, Goldberg IG, Wood ER, and Earnshaw WC (1994) ScII: An abundant chromosome scaffold protein is a member of a family of putative ATPases with an unusual predicted tertiary structure. J Cell Biol 127:303-318.
77. Ma X, Saitoh N, and Curtis PJ (1993) Purification and characterization of a nuclear DNA-binding factor complex containing topoisomerase II and chromosome scaffold protein 2. J Biol Chem 268:6182-6188.
78. Kroll DJ, Sullivan DM, GutierrezHartmann A, and Hoeffler JP (1993) Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3′,5′-monophosphate response element-binding protein and related transcription factors. Mol Endocrinol 7:305-318.
79. Nakano H, Yamazaki T, Miyatake S, Nozaki N, Kikuchi A, and Saito T (1996) Specific interaction of topoisomerase IIβ and the CD3 epsilon chain of the T cell receptor complex. J Biol Chem 271: 6483-6489.